Renin-Angiotensin System Inhibitors Prognostic Benefit in Older Patients with Atrial Fibrillation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Renin-Angiotensin System Inhibitors Prognostic Benefit in Older Patients with Atrial Fibrillation

Published:2021-10 Issue:10 Volume:22 Page:2190-2195
ISSN:1525-8610
Container-title:Journal of the American Medical Directors Association
language:en
Short-container-title:Journal of the American Medical Directors Association

Author:

Cespón-Fernández María,Raposeiras-Roubín Sergio,Abu-Assi Emad,Melendo-Viu María,García-Campo Enrique,Íñiguez-Romo Andres

Publisher

Elsevier BV

Subject

Health Policy,General Medicine,General Nursing,Geriatrics and Gerontology

Reference22 articles.

1. Upstream therapies for management of atrial fibrillation: Review of clinical evidence and implications for European Society of Cardiology Guidelines. Part I: Primary prevention;Savelieva;Europace,2011

2. Modifiable risk factors and atrial fibrillation;Lau;Circulation,2017

3. Atrial fibrillation and renin-angiotensin system;Serra;Ther Adv Cardiovasc Dis,2008

4. Atrial failure as a clinical entity: JACC review topic of the week;Bisbal;J Am Coll Cardiol,2020

5. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society;January;J Am Coll Cardiol,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation;Frontiers in Cardiovascular Medicine;2023-06-22

2. Impact of baseline blood pressure on all-cause mortality in patients with atrial fibrillation: results from a multicenter registry study;Chinese Medical Journal;2023-03-13

3. Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension;BMC Cardiovascular Disorders;2022-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3